![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Core Laboratories Inc | NYSE:CLB | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.37 | -1.63% | 22.26 | 22.86 | 22.21 | 22.37 | 308,078 | 01:00:00 |
A total of 69,708,588 common shares were voted at the Meeting, representing 53.16% of the votes attached to all outstanding common shares of the Company. Shareholders voted in favour of all items of business presented at the Meeting, including the re-election of all director nominees as follows: Joel Dumaresq, Salvatore Milia, Nicco Dehaan, Mervin Boychuk, Gil Playford and James McMillan. Shareholders also approved the re-appointment of the Company's auditor, DMCL LLP, Chartered Professional Accountants, and the renewal of the Company’s rolling stock option plan and restricted share unit plan for a further three years in accordance with the requirements of the Canadian Securities Exchange.
About Christina Lake Cannabis Corp.
Christina Lake Cannabis is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation license and corresponding processing amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development license (early 2020). Christina Lake Cannabis’ facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. Christina Lake Cannabis also owns a 99-acre plot of land adjoining its principal site. CLC focuses its production on creating high quality extracts and distillate for its B2B client base with proprietary strains specifically developed for outdoor cultivation to enhance extraction quality.
On behalf of Christina Lake Cannabis:
“Mark Aiken”Mark Aiken, CEO
For more information about CLC, please visit: www.christinalakecannabis.com
Jennifer SmithInvestor Relations and Media Inquiriesinvestors@clcannabis.com902-229-7265
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.
1 Year Core Laboratories Chart |
1 Month Core Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions